雜志介紹

Cellular Oncology雜志介紹

《Cellular Oncology》是(shi)一本以(yi)English為(wei)(wei)主的(de)(de)(de)(de)(de)未開放(fang)獲(huo)取國際(ji)優秀期(qi)刊，中文名(ming)稱細(xi)胞腫瘤學(xue)，本刊主要(yao)出版、報道(dao)醫學(xue)-CELL BIOLOGY領(ling)域(yu)(yu)的(de)(de)(de)(de)(de)研究(jiu)動態以(yi)及在該(gai)(gai)領(ling)域(yu)(yu)取得(de)的(de)(de)(de)(de)(de)各方(fang)面的(de)(de)(de)(de)(de)經驗和科研成(cheng)果，介紹該(gai)(gai)領(ling)域(yu)(yu)有(you)關(guan)本專業的(de)(de)(de)(de)(de)最(zui)新(xin)(xin)進展，探討行(xing)業發展的(de)(de)(de)(de)(de)思路和方(fang)法，以(yi)促進學(xue)術信息交流，提高(gao)行(xing)業發展。該(gai)(gai)刊已被國際(ji)權威數(shu)據庫SCIE收(shou)錄，為(wei)(wei)該(gai)(gai)領(ling)域(yu)(yu)相關(guan)學(xue)科的(de)(de)(de)(de)(de)發展起到(dao)了(le)良好(hao)的(de)(de)(de)(de)(de)推動作用，也得(de)到(dao)了(le)本專業人員的(de)(de)(de)(de)(de)廣泛認可。該(gai)(gai)刊最(zui)新(xin)(xin)影響因子為(wei)(wei)4.9，最(zui)新(xin)(xin)CiteScore 指(zhi)數(shu)為(wei)(wei)10.3。

本刊近(jin)期中國學者(zhe)發(fa)表的論(lun)文主(zhu)要(yao)有(you)：

• Comprehensive analysis of clinical prognostic features and tumor microenvironment landscape of CD11b(+)CD64(+) patients with acute myeloid leukemia

  Author: Wang, Qian; Zhang, Nan; Liu, Li; Ma, Linlu; Tan, Yuxin; Liu, Xiaoyan; Wu, Jinxian; Chen, Guopeng; Li, Xinqi; Liang, Yuxing; Zhou, Fuling

• In vivo study revealed pro-tumorigenic effect of CMTM3 in hepatocellular carcinoma involving the regulation of peroxisome proliferator-activated receptor gamma (PPAR gamma)

  Author: Wang, Jiahui; Chu, Hongjin; Wang, Zhixin; Wang, Xuebo; Liu, Xuexia; Song, Zhan; Liu, Fujun

• Research advances and treatment perspectives of pancreatic adenosquamous carcinoma

  Author: Zhang, Wen; Zhang, Jing; Liang, Xijun; Ding, Jin

• FUT8 is regulated by miR-122-5p and promotes malignancies in intrahepatic cholangiocarcinoma via PI3K/AKT signaling

  Author: Chen, Fanghua; Li, Yin; Aye, Ling; Wu, Yingcheng; Dong, Liangqing; Yang, Zijian; Gao, Qiang; Zhang, Shu

英文介紹

Cellular Oncology雜志英文介紹

The Official Journal of the International Society for Cellular Oncology

Focuses on translational research

Addresses the conversion of cell biology to clinical applications

Cellular Oncology publishes scientific contributions from various biomedical and clinical disciplines involved in basic and translational cancer research on the cell and tissue level, technical and bioinformatics developments in this area, and clinical applications. This includes a variety of fields like genome technology, micro-arrays and other high-throughput techniques, genomic instability, SNP, DNA methylation, signaling pathways, DNA organization, (sub)microscopic imaging, proteomics, bioinformatics, functional effects of genomics, drug design and development, molecular diagnostics and targeted cancer therapies, genotype-phenotype interactions.

A major goal is to translate the latest developments in these fields from the research laboratory into routine patient management. To this end Cellular Oncology forms a platform of scientific information exchange between molecular biologists and geneticists, technical developers, pathologists, (medical) oncologists and other clinicians involved in the management of cancer patients.

In vitro studies are preferentially supported by validations in tumor tissue with clinicopathological associations.